Veritable’s GE HealthCare GEHC Stock Holding History

Veritable’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,432	Closed	-$604K	–	318
2023 Q2	$604K	Sell	7,432 -103	-1%	-$8.22K	0.01%	491
2023 Q1	$618K	Buy	+7,535	New	+$538K	0.01%	480

Other funds holding GEHC

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Veritable's GEHC Position: Q3 2023 in Review

Veritable sold out of GE HealthCare (GEHC) in Q3 2023, closing a stake of 7,432 shares — an estimated $604K sold.

Veritable first reported a position in GEHC in Q1 2023 and held it in 2 quarters. The position peaked at $618K in Q1 2023. 1,106 funds tracked by Wall St. Rank hold GEHC as of Q3 2023.

Veritable reported no remaining GE HealthCare position as of Q3 2023 after selling out during the quarter.
Veritable sold 7,432 GE HealthCare shares in Q3 2023, an estimated $604K.
Veritable first reported a position in GE HealthCare in Q1 2023 and held it in 2 quarters.
Veritable's GE HealthCare position peaked at $618K in Q1 2023.
1,106 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.